Cargando...

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy

The dawn of the biologic era has been an exciting period for clinical research and patient care in rheumatoid arthritis (RA). Targeted biologic therapies have changed the outcome of this disease and made remission a realistic outcome for many patients. Tocilizumab (TCZ, Actemra(®)), is a humanized m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Patel, Aarat M, Moreland, Larry W
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2990387/
https://ncbi.nlm.nih.gov/pubmed/21116333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S14099
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!